Skip to content

Exploratory Study of Novel Coronary Heart Disease Serum Markers

Screening of Serum Proteomics Molecular Markers Related to Coronary Atherosclerosis and Its Clinical Value

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048470
Enrollment
Unknown
Registered
2021-07-09
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

stable coronary heart disease group:none
unstable coronary heart disease group:none

Sponsors

The First Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Normal control: coronary angiography was completely normal, and carotid ultrasound showed no plaque. 2. Patients with stable coronary artery disease: clinical diagnosis of stable angina pectoris; coronary angiography showed obvious atherosclerotic lesions in the coronary artery (lumen diameter stenosis> 50%). 3. Patients with unstable coronary artery disease: clinical diagnosis of acute coronary syndrome; coronary angiography shows obvious coronary artery disease (luminal diameter stenosis>50%) (thrombosis is preferred); IVUS or OCT suggest unstable plaque is also acceptable.

Exclusion criteria

Exclusion criteria: 1. Aged <18 years; 2. Severe heart failure due to heart valve dysfunction and severe arrhythmia; 3. Combined with severe liver and kidney insufficiency; 4. Combined with malignant tumor; 5. Complicated or suspected of having systemic embolic diseases such as pulmonary embolism, severe lower extremity deep vein thrombosis, etc.; 6. Combined with severe autoimmune disease, acute exacerbation of chronic inflammation in the past 1 month, severe infection and other acute inflammation history in the past 1 month; 7. There is a history of surgical trauma or severe trauma in the past 1 month, including hemorrhagic diseases, cerebral infarction, etc.; 8. Have received percutaneous coronary angiography stent placement or surgical bypass surgery in the past; 9. Being pregnant and preparing for pregnancy.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events;Left ventricular ejection fraction;

Secondary

MeasureTime frame
Left ventricular diameter;

Countries

China

Contacts

Public ContactGuo Xiaogang

The First Affiliated Hospital of Zhejiang University School of Medicine

gxg22222@zju.edu.cn+86 13867441856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026